Characterizes receptor selectivity of ecopipam in Tourette syndrome, highlighting its potential clinical relevance.
To characterize the binding/inhibition and potential clinical relevance of ecopipam and relevant metabolites across a wide array of potential off-target receptors, ion channels, enzymes, and transporters.
No takes yet. Share an insight, caveat, or question.
Wanaski et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: